These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 23127512)
1. Mitigation of radiation injury by selective stimulation of the LPA(2) receptor. Kiss GN; Lee SC; Fells JI; Liu J; Valentine WJ; Fujiwara Y; Thompson KE; Yates CR; Sümegi B; Tigyi G Biochim Biophys Acta; 2013 Jan; 1831(1):117-25. PubMed ID: 23127512 [TBL] [Abstract][Full Text] [Related]
2. Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions. Kiss GN; Fells JI; Gupte R; Lee SC; Liu J; Nusser N; Lim KG; Ray RM; Lin FT; Parrill AL; Sümegi B; Miller DD; Tigyi G Mol Pharmacol; 2012 Dec; 82(6):1162-73. PubMed ID: 22968304 [TBL] [Abstract][Full Text] [Related]
3. Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist. Patil R; Szabó E; Fells JI; Balogh A; Lim KG; Fujiwara Y; Norman DD; Lee SC; Balazs L; Thomas F; Patil S; Emmons-Thompson K; Boler A; Strobos J; McCool SW; Yates CR; Stabenow J; Byrne GI; Miller DD; Tigyi GJ Chem Biol; 2015 Feb; 22(2):206-16. PubMed ID: 25619933 [TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis. Deng W; Balazs L; Wang DA; Van Middlesworth L; Tigyi G; Johnson LR Gastroenterology; 2002 Jul; 123(1):206-16. PubMed ID: 12105849 [TBL] [Abstract][Full Text] [Related]
5. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Deng W; Shuyu E; Tsukahara R; Valentine WJ; Durgam G; Gududuru V; Balazs L; Manickam V; Arsura M; VanMiddlesworth L; Johnson LR; Parrill AL; Miller DD; Tigyi G Gastroenterology; 2007 May; 132(5):1834-51. PubMed ID: 17484878 [TBL] [Abstract][Full Text] [Related]
6. Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Brindley DN; Lin FT; Tigyi GJ Biochim Biophys Acta; 2013 Jan; 1831(1):74-85. PubMed ID: 22954454 [TBL] [Abstract][Full Text] [Related]
7. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis. Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984 [TBL] [Abstract][Full Text] [Related]
9. The LPA Kuo B; Szabó E; Lee SC; Balogh A; Norman D; Inoue A; Ono Y; Aoki J; Tigyi G Cell Signal; 2018 Nov; 51():23-33. PubMed ID: 30063964 [TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq. Kim J; Keys JR; Eckhart AD Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line. Zhang Z; Liu Z; Meier KE Am J Physiol Cell Physiol; 2006 Nov; 291(5):C1089-98. PubMed ID: 16760261 [TBL] [Abstract][Full Text] [Related]
12. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway. Deng W; Wang DA; Gosmanova E; Johnson LR; Tigyi G Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G821-9. PubMed ID: 12684213 [TBL] [Abstract][Full Text] [Related]
13. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. Li S; Wang B; Xu Y; Zhang J Mol Cancer; 2011 Feb; 10():18. PubMed ID: 21314984 [TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential. Tigyi GJ; Johnson LR; Lee SC; Norman DD; Szabo E; Balogh A; Thompson K; Boler A; McCool WS J Lipid Res; 2019 Mar; 60(3):464-474. PubMed ID: 30692142 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of autotaxin/lysophospholipase d inhibitors. Federico L; Pamuklar Z; Smyth SS; Morris AJ Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016 [TBL] [Abstract][Full Text] [Related]
16. The autotaxin-LPA2 GPCR axis is modulated by γ-irradiation and facilitates DNA damage repair. Balogh A; Shimizu Y; Lee SC; Norman DD; Gangwar R; Bavaria M; Moon C; Shukla P; Rao R; Ray R; Naren AP; Banerjee S; Miller DD; Balazs L; Pelus L; Tigyi G Cell Signal; 2015 Sep; 27(9):1751-62. PubMed ID: 26027517 [TBL] [Abstract][Full Text] [Related]
17. Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Okudaira S; Yukiura H; Aoki J Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246 [TBL] [Abstract][Full Text] [Related]
18. ATX and LPA receptor 3 are coordinately up-regulated in lipopolysaccharide-stimulated THP-1 cells through PKR and SPK1-mediated pathways. Li S; Xiong C; Zhang J FEBS Lett; 2012 Mar; 586(6):792-7. PubMed ID: 22314276 [TBL] [Abstract][Full Text] [Related]
19. LPA rescues ER stress-associated apoptosis in hypoxia and serum deprivation-stimulated mesenchymal stem cells. Li Z; Wei H; Liu X; Hu S; Cong X; Chen X J Cell Biochem; 2010 Nov; 111(4):811-20. PubMed ID: 20533299 [TBL] [Abstract][Full Text] [Related]
20. Optimal lysophosphatidic acid-induced DNA synthesis and cell migration but not survival require intact autophosphorylation sites of the epidermal growth factor receptor. Deng W; Poppleton H; Yasuda S; Makarova N; Shinozuka Y; Wang DA; Johnson LR; Patel TB; Tigyi G J Biol Chem; 2004 Nov; 279(46):47871-80. PubMed ID: 15364923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]